Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Neuroprotective effects of the novel Glp-1 long acting analogue semaglutide in the Mptp Parkinson's disease mouse model
Actualmente est en marcha el estudio Effect of semaglutide versus placebo on the progression of renal impairment in subjects with type 2 diabetes and chronic kidney disease (FLOW), un ensayo clnico de fase 3 que incluye ms de 3.000 pacientes con DM tipo 2 y ERC moderada-severa (FGe 25-75ml/min/1.73m2 y CAC 300-5.000mg/g) (NCT03819153)
C., Chou, V
Recent study demonstrated that the expression of NE is significantly upregulated in the liver and serum during overdose APAP challenge
US$ 20.22
US$ 24.59
US$ 24.02
US$ 24.58
US$ 29.65
